An interventional study of Motivational and Individualized Interviewing and Heart-Healthy Dietary Education in Myocardial Infarction, sponsored by Sergio Mies Padilla. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-11.
Sponsored by Sergio Mies Padilla · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 131 studies in Myocardial Infarction with a site in Spain — 19 open to participants now, 27 under way, 7 of them phase 3. Myocardial Infarction · Spain.
Among the 131 studies in Myocardial Infarction with a site in Spain, this one is the 65th largest by planned enrollment of the 98 interventional ones that give a count, is one of 4 that started in 2026, is one of 29 with no phase, reaches primary completion later than 11 of the 26 other live ones, and was the 128th registered.
2,273 studies on the registry are indexed under Myocardial Infarction; 373 are open to participants now.
Browse Myocardial Infarction studies →19 of the 131 studies in Myocardial Infarction with a site in Spain are open now. Recruiting first, the newest first:
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Sites in Spain, Ireland, Latvia and 2 more countries
Ages 18+
Fundación para la Investigación del Hospital Clínico de Valencia · Sites in Spain
Ages 65+
Novo Nordisk A/S · Sites in Spain, Austria, Denmark and 3 more countries
Ages 18+
Instituto de Investigación Biomédica de Salamanca · Sites in Spain
Ages 18+
Abcentra · Sites in Spain, United States, Czechia and 6 more countries
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 256 Myocardial Infarction studies recruiting now, 173 (68%) set no upper age limit and 25 (10%) stop at 75 or younger; 17 take children under 18; 27 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
131 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 18 · Phase 3 35 · Phase 4 16
First in 2002; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 256 is above the median of 150 across 1,317 interventional studies indexed under Myocardial Infarction.
Median enrollment 445 across the 98 interventional studies, 1,498 across the 33 observational. Of the 91 that completed or were terminated, 29 (32%) have results posted.
This tab as a report to print or save as PDF → With an account.
51 of 131 have an industry lead sponsor. The 10 most frequent:
Sergio Mies Padilla is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Sergio Mies Padilla has 1 study filed under Myocardial Infarction — fewer than ten, so there is no comparison to draw.
8 of the studies in Myocardial Infarction with a site in Spain that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06118281Phase 3Novo Nordisk A/SARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack | 2027-01-29 |
| NCT04957719Phase 3Viatris Innovation GmbHSelatogrel Outcome Study in Suspected Acute Myocardial Infarction | 2027-07 |
| NCT06799780IRCCS Azienda Ospedaliero-Universitaria di BolognaStudy on Post-acute Myocardial Infarction Ventricular Defect: Outcome Evalutation in Relation to Surgical Timing | 2026-11-30 |
| NCT04973397Centre hospitalier de l'Université de Montréal (CHUM)Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study | 2026-12 |
| NCT07268391Instituto de Investigación Biomédica de SalamancaUsing Advanced CT Scans and Blood Markers to Better Understand Heart Damage and Recovery After a Heart Attack | 2027-01 |
Add all 8 to your calendar (.ics) → With an account.
Among the 131 studies in Myocardial Infarction with a site in Spain, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Early Education After a Heart Attack What is the purpose of this study? The main goal is to evaluate if a special nursing education and support program helps patients who have suffered a heart attack feel more confident in managing their own health. Researchers want to see if this extra support improves how patients care for their hearts through diet, physical activity, and quitting smoking. The study compares this new nursing strategy against the standard care patients usually receive.
Who can participate? Participants must be 18 years of age or older. People who have recently had a heart attack requiring an urgent heart catheterization at the Complejo Hospitalario Universitario Insular Materno Infantil.
Exclusions: People with significant language barriers (Spanish), mental incapacity to follow recommendations, or those unable to attend in-person consultations cannot participate.
What will happen during the study? Participants will be divided into two groups: Standard Care Group (Control): These participants will receive the usual medical follow-up and standard cardiac rehabilitation sessions (an average of 17 sessions focused on exercise and group education). Special Support Group (Experimental): In addition to standard care, these participants will have a specific nursing consultation consisting of 4 scheduled visits.
These visits are a mix of in-person and telephone appointments.Nurses will provide personalized educational materials, such as infographics, and teach techniques to control blood pressure, improve diet, exercise safely, and manage emotions after a heart attack.
Duration and Follow-up Each participant will be followed for approximately 8 months. During this time, they will be asked to complete several surveys about their lifestyle.
Researchers will also review blood test results (cholesterol levels) from their medical records to track progress.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The intervention for the experimental group consists of specialized and structured nursing care provided in addition to standard medical treatment. This program is organized into four key stages: it begins with an initial contact during hospital admission to explain the objectives and assess baseline risks. Subsequently, between 7 and 10 days after discharge, a 60-minute in-person visit is conducted to perform a complete medical history and deliver adapted educational materials on heart-healthy habits. Four months after the event, a telephone reinforcement session is held to monitor treatment adherence and lifestyle changes. Finally, eight months after discharge, an in-person evaluation is carried out to measure the achievement of goals and, if necessary, refer the patient to other specialists. The entire process is supported by the use of infographics and evidence-based educational materials focused on blood pressure control, diet, exercise, and emotional health.
Behavioral: Motivational and Individualized Interviewing · Behavioral: Heart-Healthy Dietary Education · Behavioral: Tobacco Cessation Approach · Behavioral: Physical Activity Promotion · Behavioral: Emotional Health Management · Behavioral: Therapeutic Adherence Reinforcement · Behavioral: Self-Control Training · Behavioral: Use of Educational Resources · Other: Cardiac Rehabilitation Program
The Control Group consists of patients who receive the standard healthcare provided by the hospital after a heart attack. These participants are recruited retrospectively using the hospital's hemodynamic service records. After discharge, they participate in the standard cardiac rehabilitation program, which typically includes 17 sessions of physical exercise and group health education. Their data is collected through a single telephone interview approximately 8 months after their heart attack to evaluate their lifestyle habits, emotional state, and clinical progress.
Other: Cardiac Rehabilitation Program
Used to verify the patient's understanding of their condition and to motivate behavioral changes.
Specific counseling to improve adherence to the Mediterranean diet and address overweight or obesity
Interventions aimed at increasing motivation to quit smoking and reducing nicotine dependence
Personalized exercise recommendations tailored to the patient's clinical status
Professional support to address emotional well-being, detecting potential states of anxiety or depression following the acute event.
Continuous education and monitoring to ensure compliance with the prescribed pharmacological plan
Training the patient for autonomous monitoring of risk factors, such as blood pressure
Provision of adapted materials (infographics and written documents) to permanently reinforce healthy knowledge and behaviors
Upon hospital discharge, all patients are referred to a cardiac rehabilitation unit. The program consists of an average of 17 sessions focused primarily on the physical rehabilitation of the patient. Patients receive group-based health education provided by nursing professionals during these sessions.These rehabilitation sessions are typically completed within three months following the coronary event. Patients continue to receive medical and nursing attention through specialized care centers or primary care. Both groups receive optimal pharmacological treatment and general advice on cardiovascular health, including physical activity and diet.
Cardiac Self-Efficacy
His measure evaluates specific behaviors related to cardiovascular health using the Spanish-validated version of the Cardiac Self-Efficacy Scale (S-CSE). This tool consists of 12 items across three dimensions: symptom control, disease control, and activity maintenance. Each item is rated on a 7-point Likert scale (1 = not at all confident, 7 = completely confident). Total scores range from 12 to 84, where higher scores indicate better self-efficacy
Time frame: Experimental Group: measured at two time points: baseline (during hospitalization) and 8 months (post-coronary event). Control Group: measured only at the 8-month mark post-coronary event to evaluate the level of self-efficacy after receiving standard
Adherence to the Mediterranean Diet
Measured using the MEDAS questionnaire (14 items). Higher scores indicate greater adherence to a heart-healthy diet
Time frame: Experimental Group: baseline and 8 months Control Group: 8 months only
Nicotine Dependence
Assessed using the Fagerström Test (6 items). Scores range from 0 to 10, where greater than or equal to 7 indicates high dependence
Time frame: Experimental Group: baseline and 8 months Control Group: 8 months only
Motivation to Quit Smoking
Evaluated through the Richmond Test (4 items). Scores range from 0 to 10; scores between 8-10 indicate high motivation.
Time frame: Experimental Group: Baseline and 8 months . Control Group: 8 months only.
Physical Activity Level
Measured using the International Physical Activity Questionnaire (IPAQ). It categorizes patients into high, moderate, or low activity levels based on METs.
Time frame: Experimental Group: Baseline and 8 months Control Group: 8 months only.
Affective State (Anxiety and Depression)
Determined using the Goldberg Scale. It consists of two subscales (anxiety mayor o igual a 4 and depression greater than or equal to 2) to detect psychological distress
Time frame: Experimental Group: Baseline and 8 months Control Group: 8 months only
Lipid Profile
Clinical data collection of total cholesterol, LDL, HDL, and triglycerides from medical records
Time frame: Experimental Group: Baseline and 8 months Control Group: 8 months only
Cardiac Rehabilitation Adherence
Exploration of patient inclusion, adherence (number of sessions attended), and group education received
Time frame: 8 months (for both groups)
Plan to share: No — Currently, there is no plan to share individual participant data (IPD) with external researchers or public platforms. According to the protocol, the collected data will be used exclusively for the research purposes of this specific study, and only the research team will have access to the anonymized database. Patient privacy is protected by current regulations (Spanish Organic Law 3/2018), ensuring that information is treated confidentially and securely within the hospital environment.
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Jan 2027, 11 months after the start.
Of 322 non-industry interventional studies with no phase under Myocardial Infarction, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 58. This study's planned 11 months is below that.
Counting every sponsor, half of 355 studies reached it within 34 months; a quarter within 15 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sergio Mies Padilla